Evidence map›Paper›PMID 42620515›Full record

ArticleResearch square2026

Breast Cancer Liver Metastasis: Primary tumor predictors and histopathologic characteristics of metastatic lesions.

Pepper Schedin, Hatun Duran Cete, Jackie Phipps, Alexandra Bartlett, Michelle Ozaki, Skye Mayo

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pepper SchedinOregon Health and Science University.ORCID 0000-0003-4244-987X
Hatun Duran CeteOregon Health & Science University.ORCID 0009-0006-4208-9279
Jackie PhippsOregon Health & Science University.
Alexandra BartlettORCID 0000-0001-7912-6084
Michelle OzakiOregon Health & Science University.
Skye MayoOregon Health & Science University.

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
NSAIDs During Postpartum Involution for Breast Cancer ChemopreventionR01CA169175 · NCI · UNIVERSITY OF COLORADO DENVER · PI SCHEDIN, PEPPER J · 2013 to 2024
$4.8M
IRACDA at OHSUK12GM150451 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Angela Renee Ozburn · 2023 to 2026
$3.2M
NCATS NIH HHS UL1 TR002369NCI NIH HHS P30 CA069533NCI NIH HHS R01 CA169175NIGMS NIH HHS K12 GM150451
6 · The paper itself

Abstract

Young breast cancer patients have increased risk for liver metastasis (BCLM), implicating age-dependent organotropism. To explore potential risk factors and mechanisms of BCLM, we unbiasedly recruited 47 patients diagnosed with BCLM at a tertiary medical center, collected clinicopathologic data of the primary breast cancers, and obtained paired BCLM lesion tissue. Compared to the overall breast cancer patient population, our BCLM cohort was enriched ~4 fold for young patients (YOBC) and ~5 fold for patients diagnosed within 10 years of recent childbirth. The majority of primary breast cancer diagnoses were luminal A, low-grade and early-stage disease, clinical attributes classically associated with good prognosis. Most BCLM lesions were also ER-positive, and the dominant breast cancer growth pattern was replacement. Immunohistology staining infers utilization of existing liver sinusoids, consistent with a passive mechanism of metastatic invasion. In sum, these data suggest that the liver readily supports metastatic establishment of early-stage, luminal A breast cancer cells. These data also support a growing body of literature linking postpartum liver biology to increased risk for BCLM, providing potential insight into the observed age-dependent organotropism of BCLM. Improved understanding of reproductive risk factors for BCLM may improve patient risk stratification and outcomes overall.

Indexed as

breast cancer liver metastasisestrogen receptor conversionliver tropismpostpartum breast cancerreplacement growthsinusoidal endothelial cellsYoung onset breast cancer

Identifiers

PMID42620515
PMCPMC13484823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.